The adrenergic receptor agonist, clonidine, potentiates the anti-parkinsonian action of the selective κ-opioid receptor agonist, enadoline, in the monoamine-depleted rat-Reference-Cited by-同舟云学术

The adrenergic receptor agonist, clonidine, potentiates the anti-parkinsonian action of the selective κ-opioid receptor agonist, enadoline, in the monoamine-depleted rat

Published:1999-12 Issue:7 Volume:128 Page:1577-1585
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Hill M P,Brotchie J M

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/sj.bjp.0702943/fullpdf

Reference75 articles.

1. Feline subthalamic nucleus neurons contain glutamate-like but not GABA-like or glycine-like immunoreactivity;ALBIN;Brain Res.,1989

2. Adrenergic receptor blocking agents: effects on central noradrenaline and dopamine receptors and on motor activity;ANDEN;Psychopharmacologia,1974

3. Dopamine and noradrenaline receptor stimulation: reversal of reserpine- induced suppression of motor activity;ANDEN;Psychopharmacologia,1973

4. Characterization of the alpha-2C adrenergic receptor subtype in the opossum kidney and in the OK cell line;BLAXALL;J. Pharmacol. Exp. Ther.,1991

5. α2-Adrenoceptor antagonists: A new approach to Parkinson's disease;BREFEL-COURBON;CNS Drugs,1998

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antagonism of kappa opioid receptors accelerates the development of L-DOPA-induced dyskinesia in a preclinical model of moderate dopamine depletion;Brain Research;2023-12

2. Antagonism of kappa opioid receptors accelerates the development of L-DOPA-induced dyskinesia in a preclinical model of moderate dopamine depletion;2023-08-01

3. Orientation of nanocarriers in subarachnoid space: A tweak in strategic transport for effective CNS delivery;Journal of Drug Delivery Science and Technology;2022-09

4. Dexmedetomidine protects SH‐SY5Y cells against MPP + ‐induced declining of mitochondrial membrane potential and cell cycle deficits;European Journal of Neuroscience;2021-05-20

5. Comorbidities of depression and Parkinson’s disease;The Neuroscience of Depression;2021